NASDAQ: COCHEnvoy Medical Inc Stock Ownership - Who owns Envoy Medical?
Insider buying vs selling
Have Envoy Medical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brent T. Lucas | Chief Executive Officer | 2026-05-29 | 32,856 | $0.60 | $19.68kBuy |
| Susan Kantor | Director | 2026-02-12 | 96,150 | $0.40 | $38.46kBuy |
| Brent T. Lucas | Chief Executive Officer | 2026-02-12 | 62,500 | $0.40 | $25.00kBuy |
| Glen A. Taylor | 10% Owner | 2026-02-12 | 18,750,000 | $0.40 | $7.50MBuy |
| Charles Brynelsen | Director | 2026-02-12 | 1,000,000 | $0.40 | $400.00kBuy |
| Mona Chetan Patel | Director | 2026-02-12 | 312,500 | $0.40 | $125.00kBuy |
| Robert Potashnick | Interim CFO | 2026-02-12 | 212,500 | $0.40 | $85.00kBuy |
| Brent T. Lucas | Chief Executive Officer | 2025-11-28 | 18,105 | $0.71 | $12.91kBuy |
COCH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when COCH insiders and whales buy or sell their stock.
COCH Shareholders
What type of owners hold Envoy Medical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Glen A. Taylor | 37.77% | 29,040,049 | $19.34M | Insider |
| Nantahala Capital Management LLC | 9.95% | 7,650,000 | $5.09M | Institution |
| Bleichroeder LP | 8.13% | 6,250,000 | $4.16M | Institution |
| Charles Brynelsen | 1.37% | 1,050,000 | $699.30k | Insider |
| Atlas Merchant Capital LLC | 1.17% | 900,000 | $599.40k | Insider |
| Barclays PLC | 1.17% | 897,087 | $597.46k | Insider |
| Vanguard Capital Management LLC | 1.15% | 881,672 | $587.19k | Institution |
| Dsg Capital Advisors LLC | 0.81% | 625,000 | $416.25k | Institution |
| Geode Capital Management LLC | 0.68% | 521,824 | $347.53k | Institution |
| Brent T. Lucas | 0.46% | 350,629 | $233.52k | Insider |
COCH vs Medical Device Stocks
Envoy Medical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.